1. Sakuma K, Ogawa M, Sugibayashi K, Yamada K, Yamamoto K. Relationship between tyrosinase inhibitory action and oxidation-reduction potential of cosmetic whitening ingredients and phenol derivatives. Arch Pharm Res. 1999. 22:335–339.
Article
2. Jimbow K, Obata H, Pathak MA, Fitzpatrick TB. Mechanism of depigmentation by hydroquinone. J Invest Dermatol. 1974. 62:436–449.
Article
3. Faulkner DJ. Marine natural products. Nat Prod Rep. 2002. 19:1–48.
Article
4. Proksch P, Edrada RA, Ebel R. Drugs from the seas - current status and microbiological implications. Appl Microbiol Biotechnol. 2002. 59:125–134.
Article
5. Lee JS, Lee JY, Choi YM, Jung YS, Kang WH, Kang HY. Skin organ culture model for evaluation of melanin pigmentation. Korean J Dermatol. 2005. 43:450–454.
6. Choi TY, Kim JH, Ko DH, Kim CH, Hwang JS, Ahn S, et al. Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res. 2007. 20:120–127.
Article
7. Bertolotto C, Buscà R, Abbe P, Bille K, Aberdam E, Ortonne JP, et al. Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol. 1998. 18:694–702.
Article